Renascience
4889
Tecnisco
2962
BlueMeme
4069
Flight Solutions
3753
Hisamitsu Pharmaceutical
4530
(Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 17.11%5.59B | -9.19%5.41B | 1.41%23.76B | -2.46%7.53B | 2.68%5.5B | -0.43%4.77B | 7.15%5.96B | -10.68%23.43B | 13.02%7.72B | -13.69%5.35B |
Cost of revenue | 16.65%4.44B | -15.31%3.94B | 3.80%18.54B | 0.11%5.82B | 3.05%4.26B | 8.72%3.81B | 5.44%4.65B | -14.22%17.86B | -3.00%5.81B | -13.59%4.13B |
Gross profit | 18.88%1.15B | 12.51%1.47B | -6.23%5.22B | -10.30%1.71B | 1.42%1.24B | -25.21%967.46M | 13.71%1.31B | 2.95%5.57B | 127.65%1.91B | -14.04%1.22B |
Operating expense | 5.66%1.1B | 4.29%1.03B | 3.84%4.18B | -2.51%1.14B | 3.03%1.01B | 10.64%1.04B | 5.79%990.9M | 2.44%4.03B | 1.59%1.17B | 10.25%980.98M |
Operating profit | 165.63%49.02M | 38.01%440.73M | -32.53%1.04B | -22.67%569.91M | -5.16%226.7M | -121.25%-74.7M | 48.11%319.35M | 4.30%1.54B | 335.02%736.98M | -54.85%239.04M |
Net non-operating interest income (expenses) | 13.52%-5.8M | 14.35%-6.12M | 42.94%-20.3M | 68.12%-2.38M | 46.41%-4.06M | 35.80%-6.71M | 29.00%-7.14M | -28.74%-35.57M | 13.76%-7.48M | -20.43%-7.58M |
Non-operating interest income | 1.46%3.05M | 12.41%4.16M | -28.95%15.62M | 67.62%5.9M | -23.29%3.01M | -50.20%3.01M | -56.48%3.7M | 4.89%21.98M | -35.80%3.52M | -20.40%3.93M |
Non-operating interest expense | -8.88%8.85M | -5.22%10.27M | -37.59%35.91M | -24.67%8.29M | -38.52%7.07M | -41.07%9.72M | -41.58%10.84M | 18.45%57.55M | -22.30%11M | 2.49%11.51M |
Net investment income | -25.74%36.8M | -66.97%-4.77M | 164.24%66.05M | 13.90%24.53M | -56.24%-5.18M | 122.33%49.55M | 81.60%-2.86M | -20.39%25M | 236.67%21.54M | -253.47%-3.32M |
Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
Gain(Loss) on derecognition of available-for-sale financial assets | 197.74%2.64M | 498.52%4.57M | -89.91%3.01M | -243.76%-1.68M | -6.52%4.95M | -96.57%885K | -37.41%-1.15M | 688.06%29.8M | -489K | 317.73%5.29M |
Income from associates and other participating interests | ||||||||||
Special income (charges) | -93.50%-1.13M | -660.18%-633K | 74.48%-1.13M | 83.96%-614K | -159.49%-47K | -585K | 116.33%113K | -34.91%-4.44M | -4,105.49%-3.83M | 103.04%79K |
Less:Other special charges | 93.50%1.13M | 660.18%633K | -74.48%1.13M | -83.96%614K | 159.49%47K | --585K | -116.33%-113K | 34.91%4.44M | 4,105.49%3.83M | -103.04%-79K |
Other non-operating income (expenses) | -41.64%17.82M | -18.52%14.82M | 70.50%72.31M | -0.40%13.38M | 4,695.50%10.2M | 116.47%30.54M | 20.54%18.19M | 211.27%42.41M | 283.11%13.43M | 97.67%-222K |
Income before tax | 9,897.83%99.35M | 37.39%448.6M | -27.44%1.16B | -20.66%603.14M | -0.32%232.56M | -100.25%-1.01M | 60.37%326.51M | 11.38%1.6B | 335.13%760.16M | -54.32%233.3M |
Income tax | 456.95%28.18M | 29.87%147.25M | -26.28%366.15M | -16.44%211.56M | -44.41%36.15M | -96.04%5.06M | 122.96%113.39M | -5.37%496.66M | 827.05%253.17M | -58.33%65.02M |
Net income | 1,271.96%71.17M | 41.40%301.35M | -27.97%795.04M | -22.76%391.59M | 16.72%196.41M | -102.20%-6.07M | 39.53%213.12M | 21.02%1.1B | 275.75%506.99M | -52.56%168.27M |
Net income continuous operations | 1,271.97%71.17M | 41.40%301.35M | -27.97%795.04M | -22.76%391.59M | 16.72%196.41M | -102.20%-6.07M | 39.53%213.12M | 21.02%1.1B | 275.75%506.99M | -52.56%168.27M |
Noncontrolling interests | -221.21%-40K | 84.00%-8K | -40.55%1.31M | 28.92%633K | -10.42%696K | -91.15%33K | -108.83%-50K | -23.84%2.21M | 6.05%491K | -2.02%777K |
Net income attributable to the company | 1,266.30%71.21M | 41.37%301.35M | -27.94%793.73M | -22.81%390.96M | 16.84%195.71M | -102.22%-6.11M | 40.08%213.17M | 21.16%1.1B | 275.30%506.5M | -52.67%167.5M |
Preferred stock dividends | ||||||||||
Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Net income attributable to common stockholders | 1,266.30%71.21M | 41.37%301.35M | -27.94%793.73M | -22.81%390.96M | 16.84%195.71M | -102.22%-6.11M | 40.08%213.17M | 21.16%1.1B | 275.30%506.5M | -52.67%167.5M |
Gross dividend payment | ||||||||||
Basic earnings per share | 1,255.32%5.43 | 41.39%22.92 | -27.95%60.36 | -22.82%29.73 | 16.88%14.89 | -102.24%-0.47 | 40.10%16.21 | 21.16%83.77 | 275.25%38.52 | -52.67%12.74 |
Diluted earnings per share | 1,255.32%5.43 | 41.39%22.92 | -27.95%60.36 | -22.82%29.73 | 16.84%14.885 | -102.24%-0.47 | 40.10%16.21 | 21.16%83.77 | 275.25%38.52 | -52.67%12.7394 |
Dividend per share | 0 | 0 | 20.00%18 | 20.00%18 | 0 | 0 | 0 | 0.00%15 | 0.00%15 | 0 |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |